Evidence map›Paper›PMID 33923745›Full record

ArticlePharmacy (Basel, Switzerland)2021

Stakeholder Views on the Idea of Medicines Reuse in the UK.

Parastou Donyai, Rachel McCrindle, Terence K L Hui, R Simon Sherratt

Abstract read
In one paragraph

Article in Pharmacy (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Parastou DonyaiReading School of Pharmacy, University of Reading, P.O. Box 226, Whiteknights, Reading RG6 6AP, UK.ORCID 0000-0001-5403-6170
Rachel McCrindleDepartment of Biomedical Engineering, School of Biological Sciences, University of Reading, Whiteknights, Reading RG6 6AY, UK.
Terence K L HuiDepartment of Biomedical Engineering, School of Biological Sciences, University of Reading, Whiteknights, Reading RG6 6AY, UK.ORCID 0000-0002-7513-1887
R Simon SherrattDepartment of Biomedical Engineering, School of Biological Sciences, University of Reading, Whiteknights, Reading RG6 6AY, UK.ORCID 0000-0001-7899-4445

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

People's views about medicines reuse are being examined in a handful of qualitative studies and this commentary adds to that work by drawing on our own discussions with groups of stakeholders in the UK in the past two years. The reuse of medicines within the community pharmacy setting is not permitted in the UK but our multidisciplinary team anticipates that this position will change in the coming years as medication shortages and worries about environmental waste and financial losses from the destruction of unused medicines are brought to the fore. Indeed, for many stakeholders, the issue of waste is a strong feature of conversations about medicines reuse. In addition to this, stakeholders identify the numerous barriers to medicines reuse in the UK. This includes the current uncertainty about the quality of unused medicines returned to pharmacies, which could otherwise be reused. However, stakeholders have also been very willing to propose solutions to a range of existing barriers. Our commentary draws on stakeholder meetings to elaborate the range of views about medicines reuse within a UK context. The challenge is to move forward from these views to advance the technologies that will facilitate medicines reuse practically as well as legally.

Indexed as

attitudesmedicinesmedicines reuserecyclereuse

Identifiers

PMID33923745
PMCPMC8167662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.